Effect of Intraperitoneal Administration of Low-Molecular-Weight Heparin on Plasma Tissue Factor Pathway Inhibitor Levels in CAPD Patients

• Published in: Nephron Vol. 91; no. 1; pp. 162 - 163
• Main Authors: Demirkan, Fatih, Akarsu, Mesut, Sifil, Aykut, Tutucu, Kutlay Naci
• Format: Journal Article
• Language: English
• Published: Basel, Switzerland S. Karger AG 01.05.2002
• Subjects: Anticoagulants - administration & dosage; Anticoagulants - pharmacology; Enzyme-Linked Immunosorbent Assay; Factor Xa - metabolism; Female; Heparin, Low-Molecular-Weight - administration & dosage; Heparin, Low-Molecular-Weight - pharmacology; Humans; Injections, Intraperitoneal; Lipoproteins - blood; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Short Communication; Continuous ambulatory peritoneal dialysis; Intraperitoneal low-molecular-weight heparin; Tissue factor pathway inhibitor

We investigated the systemic effect of intraperitoneal low-molecular-weight heparin (LMWH) in continuous ambulatory peritoneal dialysis (CAPD) patients by measuring plasma total tissue factor pathway inhibitor (TFPI) levels, regarding the fact that the levels of plasma TFPI increases 2- to 4-fold af...